Global Health Notes: RSV Bright News, Hep A in Kerala, Sickle Cell & Climate + more

TOP THREE

1. REAL-WORLD RESULTS CONFIRM SAFETY OF RSV VACCINE IN PREGNANCY

A new study, examining real-world data from thousands of women who received the respiratory syncytial virus (RSV) vaccine during pregnancy to protect their newborns,has provided further reassurance that the vaccine is safe.

2. INSIDE THE STORM: HOW SOARING HEPATITIS A RATES ARE AFFECTING KERALA

Kerala is grappling with a severe hepatitis A outbreak, with cases skyrocketing to over 6,000 in early 2024. Contaminated water sources and climate change are major factors. Health officials are calling for increased vaccination.

3. ?NIGERIAN 'SICKLE CELL WARRIORS' FACE NEW FOE: CLIMATE CHANGE

Nigerian sickle cell patients are struggling with worsening health due to climate change. Extreme weather is heightening their risk of infections, with experts urgingadaptation strategies as rising temperatures and unpredictable weather intensify the patients’ struggle.

IN BRIEF

? In Dhaka, drug-resistant TB cases are rising, challenging patients and the healthcare system, despite free treatment and improved success rates..

? A church initiative in Kisumu, Kenya is providing young mothers with vital health care after severe floods, helping 273 children so far.

? Over 21,000 health workers shared their stories, their work and their strategies at the latest Teach to Reach event, focusing on integrating vaccinations with other health services.

VIDEO OF THE WEEK

THERAPEUTIC VACCINES

Discover the science behind these innovative treatments, which are designed to stimulate the immune system to target and destroy diseases like cancer, dengue fever, cholera, HIV and HPV.

FROM THE ARCHIVE

RSV VACCINES: ARE WE CLOSE TO TAMING ONE OF THE WORLD’S BIGGEST KILLERS OF CHILDREN?

This week we look back at key advances in the FDA approved, first-ever RSV vaccine for the elderly, marking a significant milestone in combating this severe respiratory virus. At the same time, a promising maternal RSV vaccine has alsodemonstrated over 80% efficacy for infants.

?

NOUVELLES DE LA SEMAINE

LES VACCINS THERAPEUTIQUES CONTRE LE VPH POURRAIENT SAUVER DES CENTAINES DE MILLIERS DE VIES CONTRE LE CANCER DU COL DE L'UTERUS.

?

De nouveaux vaccins thérapeutiques contre le VPH pourraient compléter les vaccins prophylactiques contre le VPH existants.